Applied DNA Sciences, Inc. (APDN)

NASDAQ: APDN · IEX Real-Time Price · USD
1.56
0.00 (0.00%)
At close: Dec 5, 2022 4:00 PM
1.62
+0.06 (3.85%)
After-hours: Dec 5, 2022 6:24 PM EST
Market Cap 20.10M
Revenue (ttm) 17.65M
Net Income (ttm) -12.23M
Shares Out 8.98M
EPS (ttm) -1.91
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 122,542
Open 1.56
Previous Close 1.56
Day's Range 1.51 - 1.63
52-Week Range 0.62 - 7.35
Beta 0.70
Analysts Buy
Price Target 7.14 (+357.7%)
Earnings Date Dec 7, 2022

About APDN

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain securi... [Read more]

Industry Electronic Equipment, Instruments & Components
Founded 1983
CEO James Hayward
Employees 78
Stock Exchange NASDAQ
Ticker Symbol APDN
Full Company Profile

Financial Performance

In 2021, APDN's revenue was $9.03 million, an increase of 367.40% compared to the previous year's $1.93 million. Losses were -$14.29 million, 9.67% more than in 2020.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for APDN stock is "Buy." The 12-month stock price forecast is 7.14, which is an increase of 357.69% from the latest price.

Price Target
$7.14
(357.69% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Why Is Applied DNA (APDN) Stock Up 70% Today?

Source: Connect world / Shutterstock.com Applied DNA (NASDAQ: APDN ) stock is rocketing higher on Monday after the company announced a massive order for its LinearDNA product. LinearDNA is an enzymatic ...

1 month ago - InvestorPlace

Applied DNA Announces Receipt of Largest Single Purchase Order for LinearDNA™ To-Date

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, announced today that it received its largest s...

1 month ago - Business Wire

Applied DNA's Biotherapeutics Subsidiary Publishes Manuscript Demonstrating that a LinearDNA™ Vaccine Candidate was P...

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (‘Applied DNA' or the “Company”), a leader in polymerase chain reaction (PCR”)-based technologies, toda...

2 months ago - Business Wire

Applied DNA and the Cornell University College of Veterinary Medicine Announce Research Collaboration to Accelerate A...

STONY BROOK, N.Y. & ITHICA, N.Y.--(BUSINESS WIRE)---- $APDN #CUCVM--Applied DNA Sciences, Inc. (NASDAQ: APDN) (‘Applied DNA' or the “Company”), a leader in polymerase chain reaction ("PCR")-based techno...

2 months ago - Business Wire

Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced it will be fe...

2 months ago - Business Wire

Applied DNA Launches Monkeypox Testing Service

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, announced today that its whol...

2 months ago - Business Wire

Applied DNA (APDN) Stock Jumps on Monkeypox Test News

Source: Viacheslav Lopatin / Shutterstock.com Applied DNA Sciences (NASDAQ: APDN ) stock is rising higher on Friday after the company sent its monkeypox test to the NYSDOH for approval. According to a p...

3 months ago - InvestorPlace

Applied DNA Submits PCR-based Monkeypox Virus Diagnostic Test for Approval to New York State Department of Health

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LDT--Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, announced today that its wholly-own...

3 months ago - Business Wire

7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher

Monkeypox stocks, our topic for today, have had a mostly mixed performance so far in 2022. It is likely, however, that they could benefit from the similar tailwinds enjoyed by companies, such as Pfizer ...

Other symbols: BVNRYCMRXGOVXSIGATNXP
3 months ago - InvestorPlace

Applied DNA Sciences (APDN) Reports Q3 Loss, Tops Revenue Estimates

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 8.33% and 19.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Applied DNA Reports Third Quarter Fiscal 2022 Financial Results

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced consolidated ...

3 months ago - Business Wire

Applied DNA Biotherapeutics Subsidiary Reports LinearDNA™ Platform Development Milestone: First Successful Administra...

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LNP--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that LineaRx, the Company's majority...

3 months ago - Business Wire

Applied DNA Awarded Extension of Health Services Contract with The City University of New York

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in polymerase chain reaction (“PCR”)-based technologies, today announced that T...

3 months ago - Business Wire

Applied DNA Receives Approximately $3.6 Million in Net Proceeds from Warrant Exercise

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in polymerase chain reaction (“PCR”)-based technologies, announced that it ha...

3 months ago - Business Wire

Applied DNA to Host Conference Call and Webcast Discussing Fiscal 2022 Third Quarter Results and Corporate Updates

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction ("PCR")-based technologies, tod...

3 months ago - Business Wire

Applied DNA Announces Closing of Upsized $12 Million Public Offering

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc., (NASDAQ: APDN) (the “Company” or “Applied DNA”), a leader in polymerase chain reaction ("PCR")-based technologies, to...

3 months ago - Business Wire

3 Monkeypox Stocks to Buy as Biden Declares Public Health Emergency

The White House has declared monkeypox a public health emergency. Within the last two weeks, California, New York and Illinois making the same declaration already, and many other states are sounding the...

Other symbols: BVNRYGOVX
4 months ago - InvestorPlace

Applied DNA stock surges again, for 4-day gain of more than 870%

Shares of Applied DNA Sciences Inc. APDN, +9.93% jumped another 15.2% in morning trading Friday, to snap back from an earlier intraday loss of as much as 8.7%. The biotechnology company's stock has now ...

4 months ago - Market Watch

Applied DNA Sciences pulls back after 6-fold surge in 2 days, after 'upsized' equity offering prices

Shares of Applied DNA Sciences Inc. APDN, -4.15% pulled back 5.1% in morning trading Thursday, after the biotechnology company announced the pricing of its "upsized" public equity offering. The stock's ...

4 months ago - Market Watch

Applied DNA Announces Pricing of $12 Million Upsized Public Offering, Priced at a Premium to Market Under Nasdaq Rules

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc., (NASDAQ: APDN) (the “Company” or “Applied DNA”), a leader in polymerase chain reaction ("PCR")-based technologies, to...

4 months ago - Business Wire

Applied DNA Sciences (APDN) Stock Soars Another 80%

Molecular technology firm Applied DNA Sciences (NASDAQ: APDN ) — which among its many specialties include polymerase chain reaction (PCR)-based solutions — recently initiated an analytical validation of...

4 months ago - InvestorPlace

Applied DNA stock soars more than 80% active trading, after quadrupling in the previous session

Shares of Applied DNA Sciences Inc. APDN, +311.16% shot up 84.0% in premarket trading, after they more than quadrupled in the previous session (up 311.2%) in the wake of the biotechnology company's anno...

4 months ago - Market Watch

A small biotech firm's stock spiked 425% after giving a positive update on a PCR test for monkeypox

A step closer to public testing for monkeypox, the update sent trading volume soaring to over 82 million shares, compared to a daily average of 153,000.

4 months ago - Business Insider

Applied DNA Sciences blasts more than 350% higher after initiating validation of monkeypox virus test

Shares of Applied DNA Sciences Inc. APDN, +390.46% skyrocketed 353.7% higher in very volatile trading Tuesday, after the biotechnology company said it initiated validation of a monkeypox virus test. Tra...

4 months ago - Market Watch